- Making Pharma Industry: “The turning point of Made in India pharmaceuticals: India is keen to establish its economy and the pharmaceutical sector is an example of the country’s ambition, which is taking important steps to become a key player globally” (Jan. 29, 2024)
- Dealtown: “Blackbird Startup Bags $7m And Pivots To WTF: In case you missed it: Allergies biotech startup Prota Therapeutics innoculated with $32 million in Series A1 raise” (Jan. 24, 2024)
- Business News Australia: “Aravax raises $66m for peanut allergy cure as Victoria leads the way” (Jan. 24. 2024)
- BioWorld: “Financings for Jan. 23, 2024: Biopharmas in Asia-Pacific raising money in public or private financings: Prota” (Jan. 23, 2024)
- New York Times: “Take the 30-Second Power Test You need more than strength to age well — you also need power. Here’s how to measure how much you have” includes link to a prior story “Can You Pass the 10-Second Balance Test?” (Jan. 22, 2024)
- Terence Robinson (X): “Allergies biotech startup Prota Therapeutics inoculated with $32 million in Series A1 raise” (Jan. 22, 2024)
- BioPharmaDispatch: “Australian company to progress peanut allergy candidate to late-stage trial” (Jan. 22, 2024)
- Overnight Success (LinkedIn): “More than $109M raised across Prota Therapeutics, others” (Jan. 21, 2024)
- This Week in Australian Startups #51, 21st January 2024: “Australian Funding Rounds: “Prota Therapeutics” (Jan. 21, 2024)
- This Week in Australian Startups (LinkedIn): “More than $109M raised across Prota Therapeutics, others” (Jan. 21, 2024)
- Murdoch Children’s Research Institute (MCRI) (LinkedIn): “Peanut allergy cracked” (Jan. 21, 2024)
- Nipponese News: “Funding Highlights: January 11th to January 18th” (Jan. 21, 2024)
- Sun Herald (Australia): “Breakthrough treatment curing some kids’ peanut allergies” (Jan. 20, 2024)
- Nachedeu (Russia: “Основные моменты финансирования: с 11 по 18 января: Prota Therapeutics Received $32 Million in Series A1 Funding” (Jan. 20, 2024)
- Reddit: r/DACXI: “Four Aussie startups that have raised $94.5 million already in January” (Jan. 19, 2024)
- SmartCompany: “Four Aussie startups that have raised $94.5 million already in January” (Jan. 19, 2024)
- Dynamic Business (LinkedIn): “Here’s a recap of recent funding developments from Australia, India, the US and beyond” (Jan. 19, 2024)
- Dynamic Business: “Funding highlights: January 11 to January 18” (Jan. 19, 2024)
- Les Actualites: “Faits saillants du financement : du 11 janvier au 18 janvier: Prota Therapeutics obtient un financement de série A1 de 32 millions de dollars” (Jan. 19, 2024)
- R Institute (China): “Prota Therapeutics获投2100万美元，推进花生过敏缓解疗法” (Jan. 18, 2024)
- Asia Private Equity: “SPRIM Tackles Peanut Allergy via Prota Therapeutics” (Jan. 18, 2024)
- Sharon TV: “Sharon Helps: Aging Backwards” (Jan. 18, 19 & 20, 2024)
- Axios Pro Rata: “Aussie acceleration: 🚑 Prota Therapeutics, an Australian developer of peanut allergy treatments, raised US$21m in equity and debt funding led by Singapore’s SGI. www.protatherapeutics.com” (Jan. 18, 2024)
- Axios Pro Rata (newsletter): “Aussie acceleration: 🚑 Prota Therapeutics, an Australian developer of peanut allergy treatments, raised US$21m in equity and debt funding led by Singapore’s SGI. www.protatherapeutics.com” (Jan. 18, 2024)
- Health Services Daily (LinkedIn): “Prota raises US$21m for oral peanut allergy treatment” (Jan. 18, 2024)
- Health Services Daily: “Prota raises US$21m for oral peanut allergy treatment” (Jan. 18, 2024)
- Venture Daily Digest: “Saudi Arabia’s VC Firm Raise $4 Billions Fund & SocialFi Startup Raised Millions From a16z In 24 Hours” (Jan. 18, 2024)
- The Venture Crew (X): “Startups Fundraising Updates – 18/01” (Jan. 18, 2024)
- The Venture Crew (X): “Startups Fundraising Updates – 18/01” (Jan. 18, 2024)
- VC Crafters (X): “Startups Fundraising Updates – 18/01” (Jan. 18, 2024)
- RevOperators (LinkedIn): “Prota Therapeutics Raises US $21M in Equity and Debt Financing” (Jan. 18, 2024)
- Block.CC: “Peanut Allergy Therapy Secures US$21 Million in Funding, Led by Singapore’s SPRIM” (Jan. 18, 2024)
- FinSMES: “Prota Therapeutics Raises US $21M in Equity and Debt Financing” (Jan. 18, 2024)
- Pharmacy Daily: “Prota raises over $31m for allergy drug” (Jan. 18, 2024)
- Business News Australia (LinkedIn): “Melbourne-based Prota Therapeutics has raised $U21 million to progress commercialisation of its product” (Jan. 18, 2024)
- Business News Australia: “Prota Therapeutics raises $31.6m to advance a cure for peanut allergy” (Jan. 18, 2024)
- Easy Branches (Singapore): “Prota raises US$21M led by Singapore’s SPRIM for its peanut allergy therapy” (Jan. 18, 2024)
- CrunchBase: “Debt Financing: Prota Therapeutics” (Jan. 17, 2024)
- San Francisco Biotech Networks (LinkedIn): “News Briefing: Lee’s Pharma to develop Windtree drug in China; Acurx shares PhIIb antibiotic data; Granata raises $14M Plus, news about Prota Therapeutics and Vaxart” (Jan. 17, 2024)
- Nestia: “Prota raises US$21M led by Singapore’s SPRIM for its peanut allergy therapy” (Jan. 17, 2024)
- Lucid Quest (LinkedIn): “News Briefing: Lee’s Pharma to develop Windtree drug in China; Acurx shares PhIIb antibiotic data; Granata raises $14M Plus, news about Prota Therapeutics and Vaxart” (Jan. 17, 2024)
- EndPoiunts News: “News Briefing: Lee’s Pharma to develop Windtree drug in China; Acurx shares PhIIb antibiotic data; Granata raises $14M Plus, news about Prota Therapeutics and Vaxart” (Jan. 17, 2024)
- TN Global (LinkedIn): “Australia’s Prota Therapeutics secures $21M in financing led by SPRIM Global Investments” (Jan. 17, 2024)
- TDPel Media: “Prota Therapeutics Secures Substantial Funding Led by SPRIM Global Investments, Propelling Accelerated Phase 3 Clinical Investigation for Revolutionary PRT120 Oral Therapy Targeting Peanut Allergy” (Jan. 17, 2024)
- KrAsia (Singapore): “Deals in brief: Meals In Minutes, Meiro, and Prota Therapeutics secure funding, ABC Impact reaches first close of second fund, multiple China and India deals, and more” (Jan. 17, 2024)
- Bio101: “Prota Therapeutics secured A$31million financing round” (Jan. 17, 2024)
- Startup Rise – Asia Pacific: “Prota Therapeutics US$21 MN Financing Led by SPRIMG Global Investments” (Jan. 17, 2024)
- Startup Daily: “Allergies biotech startup Prota Therapeutics inoculated with $32 million in Series A1 raise” (Jan. 17, 2024)
- Incubees: “SPRIM Global Investments led $21 M Debt & Equity funding raised by Prota Therapeutics” (Jan. 17, 2024)
- International Kini: “Prota Raises US$21M Led By Singapore’s SPRIM For Its Peanut Allergy Therapy” (Jan. 17, 2024)
- BeamStart: “In brief: Several companies secure funding, including Meals In Minutes, Meiro, and Prota Therapeutics, while ABC Impact reaches the first close of its second fund, and multiple deals are announced in China and India” (Jan. 17, 2024)
- BeamStart: “Peanut Allergy Therapy Secures US$21 Million in Funding, Led by Singapore’s SPRIM” (Jan. 17, 2024)
- e27: Asia Tech News (via X): “Singapore-based health sciences VC firm SPRIM Global Investments has led the US$21 million funding round (equity and debt) of Australian biotech firm Prota Therapeutics. #e27news #biotech https://e27.co/prota-raises-us21m-led-by-singapores-sprim-for-its-peanut-allergy-therapy-20240117/” (Jan. 17, 2024)
- e27: Asia Tech News: “Prota raises US$21M led by Singapore’s SPRIM for its peanut allergy therapy The fresh funding will be used to advance the development of Prota’s peanut allergy remission oral therapy” (Jan. 17, 2024)
- Philanthropy News Digest: “Singapore’s SPRIM Global anchors $21m funding in Australia’s Prota Therapeutics” (Jan. 16, 2024)
- Deal Street Asia: “Singapore’s SPRIM Global anchors $21m funding in Australia’s Prota Therapeutics” (Jan. 16, 2024)
- TechNode Global: “Australia’s Prota Therapeutics secures $21M in financing led by SPRIM Global Investments” (Jan. 16, 2024)
- Net Dace: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Lion City News: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Taiwan Sun: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Singapore News Net: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- India Gazette: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Japan Herald: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Hong Kong Herald: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Beijing News Net: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Bombay News Net: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- China National News: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Fox 44 News: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Minyanville: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Northwest Investments: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Street Insider: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Value Investing News: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Wall Steet Select: “Prota Therapeutics US$21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Boston Herald: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Sacramento News Net: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Oregon Family Magazine: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- CBS 17: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- ABC 27: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Drug Discovery & Development: “SPRIM Global Funds Prota’s Promising Peanut Allergy Treatment That Results in Remission, Not Just Desensitization” (Jan. 16, 2024)
- Associated Press: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Yahoo Finance!: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Pharmiweb (LinkedIn): “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Pharmiweb: “Prota Therapeutics US $21 Million Financing Led by SPRIM” (Jan. 16, 2024)
- World News: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- iNewsAU: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Digital Journal: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Livermore: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Kuala Lumpur Week: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Business News Philippines: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Skxox (China): “全球与中国食物过敏诊断行业：营收规模及增长分析_云同盟” (Jan. 16, 2024)
- North Korea Times: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16. 2024)
- Big News Network: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16. 2024)
- PharmaCompas: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- BioSpace: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Canadian Insider: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Business News Asia (Philippines): “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Alpha Maven: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments BioSpace” (Jan. 16, 2024)
- BioWorld: “Financings for Jan. 16, 2024: Biopharmas raising money in public or private financings, including: Alto, Cyrano, Defence, Delsitech, Disco, Prota, Stalicla, Vaxart, Xortx” (Jan. 16, 2024)
- CrunchHK (Hong Kong): “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Yes Milano: “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- ACN Newswire (LinkedIn): “Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments” (Jan. 16, 2024)
- Bulldog Reporter: “PR forecasters offer key media, business, life sciences and tech predictions for 2024” (Jan. 16, 2024)
- CommPro: “Birnbach Communications Issues Key Media, Business And Tech Predictions For 2024” (Jan. 11, 2024)
- eTradeWire: “Birnbach Communications Issues Key Media, Business and Tech Predictions for 2024” (Jan. 10, 2024)
- OpenPR: “Birnbach Communications Issues Key Media, Business and Tech Predictions for 2024” (Jan. 9, 2024)
- PRLog: “Birnbach Communications Issues Key Media, Business and Tech Predictions for 2024” (Jan. 9, 2024)
- Sharon Community TV: “Sharon Helps: Helping Seniors with Holiday Stress” (Jan. 3 & 4)
